Antibody studies of sera from patients with breast cancer
Estes, N.C.; Morse, P.A.; Humphrey, L.J.
Surgical Forum 25(0): 121-123
1974
ISSN/ISBN: 0071-8041 PMID: 4612763 Document Number: 78146
Document emailed within 1 workday
Related Documents
Stacker, S.A.; Thompson, C.H.; Sacks, N.P.; Tjandra, J.; Lowe, M.G.; Bishop, J.; McKenzie, I.F. 1988: Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2 Cancer Research 48(24 Part 1): 7060-7066Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Kuwajima, S. 1986: Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines Hokkaido Journal of Medical Science 61(1): 5-14
Magnani, J.L.; Steplewski, Z.; Koprowski, H.; Ginsburg, V. 1983: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin Cancer Research 43(11): 5489-5492
Edynak, E.M.; Hirshaut, Y.; Bernhard, M.; Trempe, G. 1972: Fluorescent antibody studies of human breast cancer Journal of the National Cancer Institute 48(4): 1137-1143
Tanaka, F.; Sawada, K.; Yonemoto, R.H. 1980: Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition Gan 71(5): 589-595
Quaranta, M.; Daniele, A.; Coviello, M.; Savonarola, A.; Abbate, I.; Venneri, M.Teresa.; Paradiso, A.; Stea, B.; Zito, A.; Labriola, A.; Schittulli, F. 2006: c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation Tumori 92(4): 311-317
Scheinberg, M.A.; Cathcart, E.S. 1976: Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis Clinical and Experimental Immunology 24(2): 323-327
Ohta, M.; Ohta, K.; Mori, F.; Itoh, N.; Nishitani, H.; Hayashi, K. 1990: Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis Clinical Chemistry 36(6): 911-913
Budde, E. 1970: Conjugation of toxoplasma antibody-containing sera with fluorescein isothiocyanate. Complement fixation test, indirect fluorescent antibody reaction and serum dye test as test criteria for the sera to be selected Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 213(2): 263-269
Giai, M.; Natoli, C.; Sismondi, P.; Biglia, N.; Lesti, G.; Mulieri, M.; Iacobelli, S. 1990: Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer Anticancer Research 10(1): 119-121
Oosting, J.D.; Derksen, R.H.; Blokzijl, L.; Sixma, J.J.; de Groot, P.G. 1992: Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity--studies in a thrombosis model Thrombosis and Haemostasis 68(3): 278-284
Palencia, C.; Wicke, L.; Kärcher, K.H.; Gitsch, E.; Hernuss, P.; Steffen, C. 1976: Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation Wiener Klinische Wochenschrift 88(15): 495-501
Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Idica, A.; Sasaki, N.; Hardy, S.; Terasaki, P. 2006: Unexpected frequencies of HLA antibody specificities present in sera of multitransfused patients Clinical Transplants 2006: 139-159
Murray, J.L.; Macey, D.J.; Grant, E.J.; Rosenblum, M.G.; Kasi, L.P.; Zhang, H.Z.; Katz, R.L.; Riger, P.T.; LeBherz, D.; Bhadkamkar, V. 1995: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Research 55(23 Suppl): 5925s-5928s
Vold, B.S.; Kraus, L.E.; Rimer, V.G.; Coombes, R.C. 1986: Use of a monoclonal antibody to detect elevated levels of a modified nucleoside, N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, in the urine of breast cancer patients Cancer Research 46(6): 3164-3167
Subramaniam, S.; Marar, T.; Devi, C.S. 1991: Studies on the changes in plasma lipids and lipoproteins in CMF treated breast cancer patients Biochemistry International 24(6): 1015-1024
Kohno, Y.; Naito, N.; Saito, K.; Hoshioka, A.; Niimi, H.; Nakajima, H.; Hosoya, T. 1989: Anti-thyroid peroxidase antibody activity in sera of patients with systemic lupus erythematosus Clinical and Experimental Immunology 75(2): 217-221